> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guidance on Drug Development for Anthrax
- URL: https://www.fdaweb.com/guidance-on-drug-development-for-anthrax/
- Published: 2016-02-16T12:00:00.000Z
- Updated: 2026-09-15T02:36:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5134779

*Federal Register* Notice: FDA is making available a draft guidance for industry entitled *Anthrax: Developing Drugs for Prophylaxis of Inhalational Anthrax.* Its purpose is to assist sponsors in the development of new drugs for this indication. This draft guidance supersedes the draft guidance entitled Inhalational Anthrax (Post-Exposure) — Developing Antimicrobial Drugs issued in 3/2002\. To download this guidance, click [here](http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070986.pdf?ref=fdaweb.com). To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-02-16/pdf/2016-02964.pdf?ref=fdaweb.com)